Maze Therapeutics MAZE
NASDAQ MAZE
$27.18 +0.16 (+0.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) Change in Receivables (2026)

Updated

Maze Therapeutics (MAZE) recorded Change in Receivables of $20 million in Q1 2026.

Analysis

Maze Therapeutics (MAZE) Change in Receivables (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Maze Therapeutics 1.51 Bn 1.51 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 20.00 Mn
API Access

Maze Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=MAZE&period=max&api_key=YOUR_API_KEY